This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange dropped 16.73 points to 797.17 Tuesday. Despite this unpleasantness, some stocks are not doing badly. Dr. Sabine Mai's shell graduate, 3D Signatures Inc. (DXD), began trading today. It reached an intraday high of 55 cents before closing at 50 cents on 232,200 shares.

3D Signatures is working on a diagnostic device for Alzheimer's disease and 13 types of cancers. Dr. Mai, a molecular biologist, is a professor at the University of Manitoba and a co-founder of 3D Signatures' private predecessor. She is the shell graduate's largest shareholder with 12,002,169 shares or 25.8 per cent. She is also a director.

3D Signatures went public through Joe Boury's capital pool shell, Plicit Capital Corp. Mr. Boury, an engineer and one-time shell-maker, listed Plicit in February, 2012, with a $600,000 initial public offering of shares at 10 cents. For its qualifying transaction, Plicit rolled back 1 for 2, which left it with 5.05 million postconsolidated shares issued, then it issued 25,323,161 postconsolidated shares to its QT target's shareholders. Mr. Boury took four years and two attempts to close a QT for his shell, but the second attempt, the 3D Signatures deal, seems promising so far for Plicit's IPO shareholders. Considering the 1-for-2 rollback, their break-even price per share is 20 cents.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS